The Patent Finder

Tapestry Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Tapestry Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Back to Tapestry Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,745,6509,10-α,α-OH-taxane analogs and methods for production thereof
Term ended
Term ended Sep 28, 2025 · From the USPTO record
Term endedTerm ended Sep 28, 2025From the USPTO record
US 7,879,9049, 10-α,α-OH-taxane analogs and methods for production thereof
Term ended
Term ended Sep 27, 2024 · From the USPTO record
Term endedTerm ended Sep 27, 2024From the USPTO record
US 9,402,8249,10-α, α-OH-taxane analogs and methods for production thereof
Term ended
Ended no later than Sep 27, 2024 · From the USPTO record
Term endedEnded no later than Sep 27, 2024From the USPTO record
US 9,820,9629, 10-α, α-oh-taxane analogs and methods for production thereof
Term ended
Ended no later than Sep 27, 2024 · From the USPTO record
Term endedEnded no later than Sep 27, 2024From the USPTO record
US 10,238,6219,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof
Term ended
Term ended Sep 27, 2024 · Low confidence
Term endedTerm ended Sep 27, 2024Low confidence
US 10,639,2939,10-α,α-OH-taxane analogs and methods for production thereof
Term ended
Term ended Sep 27, 2024 · From the USPTO record
Term endedTerm ended Sep 27, 2024From the USPTO record
US 6,977,295Locked nucleic acid hybrids and methods of use
Formerly held
Term ended
Term ended Apr 21, 2020 · From the USPTO record
Term endedTerm ended Apr 21, 2020From the USPTO record
US 6,245,565Recombinase Mediated DNA modifications
Formerly held
Term ended
Term ended Apr 28, 2019 · From the USPTO record
Term endedTerm ended Apr 28, 2019From the USPTO record
US 6,107,497Intermediate for use in docetaxel synthesis and production method therefor
Term ended
Term ended Mar 19, 2016 · From the USPTO record
Term endedTerm ended Mar 19, 2016From the USPTO record
US 6,825,166Molecular conjugates for use in treatment of cancer
Lapsed on the fee record
Ended Nov 30, 2012 · From the USPTO record
Lapsed on the fee recordEnded Nov 30, 2012From the USPTO record
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited